lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer

Oncolytic vaccinia virus (OVV) has demonstrated appropriate safety profiles for clinical development. Although designed to kill cancer cells efficiently, OVV sensitivity varies in individual cancers, and predictive biomarkers of therapeutic responses have not been identified. Here we found that OVV...

Descripción completa

Detalles Bibliográficos
Autores principales: Horita, Kosuke, Kurosaki, Hajime, Nakatake, Motomu, Kuwano, Nozomi, Oishi, Tetsuro, Itamochi, Hiroaki, Sato, Sho, Kono, Hiromichi, Ito, Mai, Hasegawa, Kosei, Harada, Tasuku, Nakamura, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463205/
https://www.ncbi.nlm.nih.gov/pubmed/31011626
http://dx.doi.org/10.1016/j.omto.2019.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463205/
https://www.ncbi.nlm.nih.gov/pubmed/31011626
http://dx.doi.org/10.1016/j.omto.2019.03.003

Ejemplares similares